— Know what they know.
Not Investment Advice

WST NYSE

West Pharmaceutical Services, Inc.
1W: +5.3% 1M: +15.3% 3M: +31.1% YTD: +14.4% 1Y: +47.0% 3Y: -10.3% 5Y: -4.0%
$316.42
+0.29 (+0.09%)
 
Weekly Expected Move ±7.7%
$256 $280 $303 $326 $349
NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 68 · $22.4B mcap · 70M float · 1.27% daily turnover · Short 63% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
51.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 18.8%  ·  5Y Avg: 25.0%
Cost Advantage ★
87
Intangibles
33
Switching Cost
31
Network Effect
35
Scale
83
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WST shows a Weak competitive edge (51.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 18.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$310
Low
$312
Avg Target
$315
High
Based on 2 analysts since Apr 23, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$312.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-27 Morgan Stanley $285 $315 +30 +2.8% $306.39
2026-04-27 Barclays $265 $310 +45 +1.3% $306.16
2026-02-13 UBS Dan Leonard $355 $340 -15 +37.9% $246.60
2026-02-13 Deutsche Bank $345 $315 -30 +27.3% $247.49
2026-02-13 Barclays Luke Sergott $325 $265 -60 +8.8% $243.61
2026-02-10 Jefferies David Windley $393 $295 -98 +18.0% $249.97
2026-02-03 Evercore ISI Daniel Markowitz $390 $320 -70 +34.5% $237.88
2025-12-01 Morgan Stanley Initiated $285 +4.0% $274.14
2025-10-27 Barclays $275 $325 +50 +10.7% $293.62
2025-10-24 UBS Dan Leonard $250 $355 +105 +15.5% $307.25
2025-10-24 Deutsche Bank Justin Bowers $250 $345 +95 +13.2% $304.74
2025-10-23 Evercore ISI Daniel Markowitz $350 $390 +40 +26.1% $309.28
2025-10-07 Evercore ISI Initiated $350 +30.6% $268.07
2025-10-02 Barclays $245 $275 +30 +1.3% $271.42
2025-09-15 Redburn Partners Jamie Clark Initiated $311 +20.8% $257.53
2025-06-24 Barclays Luke Sergott Initiated $245 +10.0% $222.68
2024-11-19 Jefferies David Windley $536 $393 -143 +36.5% $287.85
2024-02-06 Jefferies David Windley Initiated $536 +29.8% $413.00
2022-12-13 Deutsche Bank Initiated $250 -0.8% $251.90
2022-11-30 UBS Initiated $250 +12.2% $222.84

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
3
ROE
5
ROA
5
D/E
3
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WST receives an overall rating of B+. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-27 B B+
2026-02-17 C- B
2026-02-12 B C-
2026-02-02 B+ B
2026-01-03 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

73 Grade A+
Profitability
65
Balance Sheet
96
Earnings Quality
73
Growth
60
Value
51
Momentum
86
Safety
100
Cash Flow
77
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WST scores highest in Safety (100/100) and lowest in Value (51/100). An overall grade of A+ places WST among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
13.03
Safe Zone
Piotroski F-Score
9/9
Beneish M-Score
-1.10
Possible Manipulator
Ohlson O-Score
-10.76
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.7/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.32x
Accruals: -4.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. WST scores 13.03, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WST scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WST's score of -1.10 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. WST's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WST receives an estimated rating of AA+ (score: 94.7/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). WST's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
41.98x
PEG
2.45x
P/S
6.94x
P/B
7.62x
P/FCF
39.62x
P/OCF
25.37x
EV/EBITDA
22.24x
EV/Revenue
5.52x
EV/EBIT
26.62x
EV/FCF
38.80x
Earnings Yield
2.99%
FCF Yield
2.52%
Shareholder Yield
1.98%
Graham Number
$86.01
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 42.0x earnings, WST is priced for high growth expectations. Graham's intrinsic value formula yields $86.01 per share, 268% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.796
NI / EBT
×
Interest Burden
1.021
EBT / EBIT
×
EBIT Margin
0.207
EBIT / Rev
×
Asset Turnover
0.814
Rev / Assets
×
Equity Multiplier
1.351
Assets / Equity
=
ROE
18.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WST's ROE of 18.5% is driven by Asset Turnover (0.814), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.92%
Fair P/E
10.33x
Intrinsic Value
$77.47
Price/Value
3.24x
Margin of Safety
-223.53%
Premium
223.53%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with WST's realized 0.9% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $77.47, WST appears undervalued with a -224% margin of safety. The adjusted fair P/E of 10.3x compares to the current market P/E of 42.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$316.31
Median 1Y
$341.92
5th Pctile
$190.13
95th Pctile
$618.32
Ann. Volatility
39.4%
Analyst Target
$312.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert W. McMahon
SVP, Chief Financial Officer
$292,308 $5,836,414 $11,804,963
Eric M. Green
President and CEO, Chair of Board
$1,177,290 $3,327,048 $7,190,876
Shane A. Campbell
SVP, Chief Proprietary Segment Officer
$369,231 $1,193,204 $2,402,998
Bernard J. Birkett
Former SVP, Chief Financial Officer
$637,808 $1,101,209 $2,143,249
Annette F. Favorite
SVP, Chief Human Resources Officer
$450,000 $342,875 $1,389,925
Kimberly B. MacKay
Former SVP, General Counsel and Secretary
$487,000 $318,188 $1,258,170

CEO Pay Ratio

198:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,190,876
Avg Employee Cost (SGA/emp): $36,398
Employees: 10,800

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
10,800
+1.9% YoY
Revenue / Employee
$284,602
Rev: $3,073,700,000
Profit / Employee
$45,713
NI: $493,700,000
SGA / Employee
$36,398
Avg labor cost proxy
R&D / Employee
$6,880
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 30.3% 35.7% 31.6% 32.7% 32.7% 30.1% 23.3% 22.0% 20.7% 22.3% 21.3% 20.4% 18.9% 18.0% 17.7% 16.8% 17.5% 17.7% 16.9% 18.5% 18.53%
ROA 20.2% 23.9% 21.7% 22.4% 22.5% 20.6% 16.9% 15.9% 15.0% 16.1% 15.9% 15.3% 14.1% 13.4% 13.2% 12.5% 13.1% 13.2% 12.5% 13.7% 13.72%
ROIC 33.0% 38.6% 34.2% 35.0% 35.1% 34.5% 30.1% 29.0% 27.7% 27.8% 25.4% 24.1% 22.2% 21.1% 19.6% 19.2% 19.9% 20.1% 17.7% 18.8% 18.80%
ROCE 26.3% 30.1% 27.8% 28.3% 28.9% 27.3% 22.2% 21.2% 19.9% 21.6% 22.4% 21.4% 19.6% 18.8% 19.0% 18.5% 19.3% 19.6% 16.7% 18.5% 18.47%
Gross Margin 43.7% 40.8% 40.1% 39.6% 41.4% 39.0% 37.2% 37.8% 38.7% 38.7% 38.1% 33.3% 32.9% 35.5% 36.7% 33.3% 35.7% 36.5% 37.8% 35.1% 35.08%
Operating Margin 29.0% 26.0% 24.8% 26.0% 29.0% 27.3% 22.8% 23.4% 24.8% 25.6% 23.3% 18.3% 18.6% 22.5% 22.8% 18.4% 20.6% 21.6% 19.5% 21.0% 20.96%
Net Margin 25.9% 24.9% 20.3% 24.1% 24.4% 17.6% 14.5% 19.6% 20.6% 21.6% 18.7% 16.6% 15.9% 18.2% 17.4% 12.9% 17.2% 17.4% 16.4% 16.4% 16.43%
EBITDA Margin 33.4% 30.1% 30.1% 30.4% 33.6% 24.5% 22.8% 26.8% 29.4% 30.2% 28.0% 23.7% 24.1% 27.5% 27.5% 21.6% 25.9% 27.0% 26.0% 20.6% 20.58%
FCF Margin 11.4% 12.7% 11.7% 13.3% 13.7% 13.3% 15.2% 14.2% 13.9% 14.4% 14.1% 13.2% 12.4% 11.2% 9.6% 10.6% 11.6% 12.6% 15.3% 14.2% 14.22%
OCF Margin 19.8% 21.3% 20.6% 22.5% 23.1% 22.5% 25.1% 24.7% 24.7% 26.3% 26.3% 25.8% 26.2% 24.4% 22.6% 23.0% 22.9% 23.0% 24.6% 22.2% 22.21%
ROE 3Y Avg snapshot only 18.08%
ROE 5Y Avg snapshot only 20.82%
ROA 3Y Avg snapshot only 13.46%
ROIC 3Y Avg snapshot only 18.09%
ROIC Economic snapshot only 14.93%
Cash ROA snapshot only 16.75%
Cash ROIC snapshot only 25.53%
CROIC snapshot only 16.35%
NOPAT Margin snapshot only 16.36%
Pretax Margin snapshot only 21.16%
R&D / Revenue snapshot only 2.29%
SGA / Revenue snapshot only 12.56%
SBC / Revenue snapshot only 0.90%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 51.77 52.11 53.59 45.16 33.12 29.28 30.13 47.16 55.22 50.19 44.25 51.44 46.04 43.93 48.84 34.89 32.61 38.76 40.52 33.44 41.979
P/S Ratio 10.65 11.90 12.53 10.73 7.76 6.35 6.12 9.03 10.00 9.60 8.90 9.99 8.40 7.63 8.32 5.63 5.37 6.32 6.51 5.63 6.941
P/B Ratio 14.49 17.21 15.18 13.23 9.72 7.91 6.57 9.70 10.67 10.46 9.12 10.15 8.39 7.62 8.97 6.08 5.93 7.10 6.30 5.71 7.618
P/FCF 93.53 93.58 107.27 80.91 56.55 47.61 40.17 63.51 72.19 66.85 63.35 75.76 67.67 68.24 87.06 53.11 46.23 50.27 42.66 39.62 39.621
P/OCF 53.72 55.81 60.72 47.81 33.63 28.23 24.38 36.63 40.52 36.55 33.82 38.66 32.12 31.24 36.83 24.53 23.50 27.47 26.50 25.37 25.369
EV/EBITDA 36.84 39.22 39.82 34.12 24.46 20.82 21.14 32.63 37.79 34.36 30.47 35.14 30.90 28.76 32.07 22.05 20.68 24.45 25.29 22.24 22.242
EV/Revenue 10.54 11.79 12.37 10.58 7.61 6.20 5.92 8.83 9.80 9.40 8.72 9.80 8.21 7.44 8.26 5.57 5.31 6.26 6.39 5.52 5.518
EV/EBIT 44.11 45.83 46.25 39.56 28.32 24.30 24.85 38.71 45.55 41.18 36.38 42.49 38.20 36.05 40.53 28.22 26.29 31.10 32.46 26.62 26.620
EV/FCF 92.52 92.73 105.94 79.76 55.46 46.49 38.86 62.10 70.74 65.48 62.04 74.35 66.14 66.55 86.41 52.53 45.71 49.79 41.86 38.80 38.803
Earnings Yield 1.9% 1.9% 1.9% 2.2% 3.0% 3.4% 3.3% 2.1% 1.8% 2.0% 2.3% 1.9% 2.2% 2.3% 2.0% 2.9% 3.1% 2.6% 2.5% 3.0% 2.99%
FCF Yield 1.1% 1.1% 0.9% 1.2% 1.8% 2.1% 2.5% 1.6% 1.4% 1.5% 1.6% 1.3% 1.5% 1.5% 1.1% 1.9% 2.2% 2.0% 2.3% 2.5% 2.52%
PEG Ratio snapshot only 2.450
Price/Tangible Book snapshot only 5.933
EV/OCF snapshot only 24.845
EV/Gross Profit snapshot only 15.229
Acquirers Multiple snapshot only 26.700
Shareholder Yield snapshot only 1.98%
Graham Number snapshot only $86.01
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.73 2.73 2.93 2.93 2.93 2.93 3.70 3.70 3.70 3.70 2.88 2.88 2.88 2.88 2.79 2.79 2.79 2.79 3.02 3.02 3.021
Quick Ratio 2.09 2.09 2.30 2.30 2.30 2.30 2.90 2.90 2.90 2.90 2.24 2.24 2.24 2.24 2.11 2.11 2.11 2.11 2.34 2.34 2.343
Debt/Equity 0.18 0.18 0.14 0.14 0.14 0.14 0.12 0.12 0.12 0.12 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.13 0.13 0.131
Net Debt/Equity -0.16 -0.16 -0.19 -0.19 -0.19 -0.19 -0.21 -0.21 -0.21 -0.21 -0.19 -0.19 -0.19 -0.19 -0.07 -0.07 -0.07 -0.07 -0.12 -0.12 -0.118
Debt/Assets 0.12 0.12 0.10 0.10 0.10 0.10 0.09 0.09 0.09 0.09 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.10 0.10 0.098
Debt/EBITDA 0.45 0.40 0.37 0.36 0.36 0.38 0.39 0.41 0.43 0.40 0.37 0.38 0.40 0.42 0.41 0.42 0.40 0.40 0.54 0.52 0.522
Net Debt/EBITDA -0.40 -0.36 -0.50 -0.49 -0.48 -0.51 -0.71 -0.74 -0.78 -0.72 -0.65 -0.67 -0.71 -0.73 -0.24 -0.25 -0.24 -0.23 -0.48 -0.47 -0.469
Interest Coverage 72.63 86.26 90.15 88.52 90.38 81.52 90.41 85.42 72.49 71.81 80.32 83.41 88.33 123.67 159.24 219.69 498.42 1011.67 1007.67 3338.00 3338.000
Equity Multiplier 1.51 1.51 1.42 1.42 1.42 1.42 1.35 1.35 1.35 1.35 1.33 1.33 1.33 1.33 1.36 1.36 1.36 1.36 1.34 1.34 1.344
Cash Ratio snapshot only 1.208
Debt Service Coverage snapshot only 3995.000
Cash to Debt snapshot only 1.899
FCF to Debt snapshot only 1.099
Defensive Interval snapshot only 995.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.98 1.04 0.93 0.94 0.96 0.95 0.83 0.83 0.83 0.84 0.79 0.79 0.77 0.77 0.77 0.77 0.79 0.81 0.78 0.81 0.814
Inventory Turnover 5.50 5.72 4.75 4.85 4.98 4.98 4.41 4.44 4.47 4.56 4.28 4.33 4.35 4.40 4.66 4.66 4.72 4.79 4.80 5.00 5.003
Receivables Turnover 7.16 7.61 6.48 6.59 6.70 6.65 5.79 5.79 5.75 5.87 5.79 5.75 5.64 5.64 5.43 5.44 5.56 5.67 5.46 5.72 5.716
Payables Turnover 8.28 8.61 7.46 7.62 7.82 7.82 7.82 7.87 7.91 8.09 7.94 8.03 8.06 8.17 7.85 7.86 7.95 8.07 7.99 8.33 8.330
DSO 51 48 56 55 55 55 63 63 63 62 63 64 65 65 67 67 66 64 67 64 63.9 days
DIO 66 64 77 75 73 73 83 82 82 80 85 84 84 83 78 78 77 76 76 73 73.0 days
DPO 44 42 49 48 47 47 47 46 46 45 46 45 45 45 47 46 46 45 46 44 43.8 days
Cash Conversion Cycle 73 69 84 83 81 82 99 99 99 97 102 102 103 103 99 99 97 95 97 93 93.0 days
Operating Cycle snapshot only 136.8 days
Cash Velocity snapshot only 4.070
Capital Intensity snapshot only 1.326
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 29.5% 31.4% 31.9% 23.8% 16.0% 8.4% 2.0% 0.1% -2.1% 0.7% 2.2% 1.6% 0.4% -1.7% -1.9% -1.1% 2.9% 4.9% 6.3% 11.2% 11.22%
Net Income 81.7% 96.5% 91.2% 61.8% 32.0% 3.0% -11.5% -19.3% -24.3% -11.3% 1.3% 3.0% 1.2% -10.7% -17.0% -17.8% -7.1% -1.6% 0.2% 16.2% 16.16%
EPS 81.2% 96.0% 90.4% 61.3% 31.9% 3.4% -10.5% -19.0% -23.9% -10.8% 2.1% 4.9% 3.5% -8.4% -15.5% -16.4% -5.9% -0.6% 1.6% 17.1% 17.12%
FCF 3.6% 25.4% 10.9% 24.4% 39.7% 13.7% 32.9% 7.3% -1.2% 8.3% -5.7% -5.8% -10.0% -23.4% -33.3% -20.5% -3.7% 17.9% 69.6% 49.2% 49.23%
EBITDA 63.2% 68.6% 69.5% 46.3% 26.1% 7.3% -8.2% -12.6% -18.4% -7.6% 4.5% 4.7% 2.9% -7.0% -11.8% -10.5% -0.5% 3.7% 4.2% 9.3% 9.30%
Op. Income 79.8% 84.2% 78.9% 47.1% 25.2% 12.0% 0.7% -2.7% -9.1% -9.2% -5.7% -8.7% -12.0% -15.8% -16.8% -11.6% 0.9% 5.8% 3.5% 11.4% 11.38%
OCF Growth snapshot only 7.63%
Asset Growth snapshot only 17.20%
Equity Growth snapshot only 18.41%
Debt Growth snapshot only 36.49%
Shares Change snapshot only -0.82%
Dividend Growth snapshot only 3.69%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 14.6% 16.1% 18.1% 18.2% 18.3% 17.5% 16.1% 15.1% 13.7% 12.7% 11.2% 8.0% 4.5% 2.4% 0.7% 0.2% 0.4% 1.3% 2.1% 3.8% 3.77%
Revenue 5Y 11.7% 12.5% 13.4% 13.4% 13.6% 13.2% 12.5% 12.1% 11.3% 11.3% 11.4% 10.9% 10.2% 9.9% 9.4% 8.9% 8.7% 8.1% 7.4% 6.7% 6.72%
EPS 3Y 51.4% 58.8% 46.8% 45.8% 43.7% 39.9% 34.4% 28.3% 22.0% 21.8% 20.3% 11.1% 1.3% -5.5% -8.3% -10.8% -9.5% -6.7% -4.3% 0.9% 0.92%
EPS 5Y 38.2% 34.4% 35.2% 29.9% 31.2% 27.2% 31.7% 33.3% 28.3% 29.8% 23.6% 21.4% 18.5% 17.5% 15.9% 13.1% 12.1% 10.5% 8.3% 6.1% 6.07%
Net Income 3Y 51.9% 59.0% 47.3% 46.3% 44.2% 40.0% 34.3% 28.4% 22.0% 21.5% 19.7% 10.4% 0.4% -6.6% -9.4% -11.9% -10.7% -8.0% -5.5% -0.6% -0.57%
Net Income 5Y 38.5% 34.8% 35.8% 30.3% 31.2% 27.1% 31.6% 33.4% 28.5% 29.7% 23.5% 21.1% 18.1% 16.8% 15.3% 12.4% 11.3% 9.5% 7.4% 5.1% 5.10%
EBITDA 3Y 27.9% 32.7% 35.5% 34.3% 32.8% 30.2% 26.1% 22.9% 18.9% 18.7% 17.6% 10.2% 1.9% -2.6% -5.4% -6.5% -5.8% -3.7% -1.3% 0.8% 0.79%
EBITDA 5Y 23.5% 21.4% 22.9% 22.8% 24.7% 22.3% 19.9% 19.3% 16.6% 18.3% 19.0% 17.2% 14.5% 13.7% 13.1% 11.7% 11.4% 10.1% 8.4% 5.5% 5.54%
Gross Profit 3Y 23.0% 26.1% 28.9% 28.5% 27.5% 25.9% 23.1% 21.2% 18.0% 16.3% 14.0% 7.9% 1.3% -2.6% -5.0% -5.3% -4.1% -2.7% -1.0% 1.3% 1.34%
Gross Profit 5Y 15.4% 17.0% 18.5% 18.2% 18.7% 18.0% 17.1% 16.8% 15.5% 15.5% 15.7% 14.4% 12.5% 11.5% 10.5% 9.8% 9.4% 8.6% 7.6% 6.1% 6.06%
Op. Income 3Y 43.6% 47.3% 45.5% 42.4% 39.3% 36.6% 36.7% 33.2% 26.9% 23.3% 19.3% 9.3% 0.0% -5.0% -7.6% -7.7% -6.9% -6.8% -6.7% -3.5% -3.51%
Op. Income 5Y 36.0% 29.7% 30.6% 27.0% 28.3% 29.4% 28.0% 28.9% 27.5% 26.6% 24.0% 20.7% 16.7% 14.3% 14.9% 13.8% 12.7% 10.8% 7.9% 5.2% 5.16%
FCF 3Y 18.6% 21.0% 21.6% 27.2% 26.0% 21.7% 22.2% 18.4% 12.7% 15.6% 11.6% 7.9% 7.5% -1.9% -5.8% -7.0% -5.0% -0.8% 2.2% 3.8% 3.76%
FCF 5Y 33.6% 48.0% 46.4% 41.1% 37.1% 29.9% 27.1% 19.8% 18.2% 16.9% 17.6% 15.8% 12.2% 8.4% 2.8% 4.4% 4.4% 6.9% 9.5% 8.3% 8.32%
OCF 3Y 20.7% 24.4% 26.5% 30.5% 29.0% 25.1% 25.4% 23.6% 19.0% 21.3% 18.0% 14.5% 14.6% 7.1% 3.8% 0.9% 0.1% 2.0% 1.4% 0.2% 0.21%
OCF 5Y 18.3% 21.5% 21.6% 22.2% 22.4% 20.9% 22.4% 19.8% 20.0% 20.9% 21.9% 21.0% 19.1% 16.0% 12.2% 12.0% 10.0% 10.0% 9.8% 7.2% 7.25%
Assets 3Y 14.5% 14.5% 27.7% 27.7% 27.7% 27.7% 15.6% 15.6% 15.6% 15.6% 11.1% 11.1% 11.1% 11.1% 3.2% 3.2% 3.2% 3.2% 5.7% 5.7% 5.69%
Assets 5Y 10.5% 10.5% 14.1% 14.1% 14.1% 14.1% 14.2% 14.2% 14.2% 14.2% 19.2% 19.2% 19.2% 19.2% 9.2% 9.2% 9.2% 9.2% 8.9% 8.9% 8.85%
Equity 3Y 13.2% 13.2% 18.7% 18.7% 18.7% 18.7% 19.5% 19.5% 19.5% 19.5% 15.8% 15.8% 15.8% 15.8% 4.7% 4.7% 4.7% 4.7% 5.8% 5.8% 5.76%
Book Value 3Y 12.8% 13.0% 18.2% 18.3% 18.3% 18.6% 19.6% 19.4% 19.6% 19.8% 16.4% 16.6% 16.9% 17.2% 6.0% 6.1% 6.1% 6.1% 7.1% 7.3% 7.34%
Dividend 3Y 1.9% 2.0% 1.6% 1.7% 1.5% 1.8% 2.0% 1.7% 2.2% 2.1% 2.3% 2.4% 2.3% 2.5% 2.4% 2.5% 2.5% 2.6% 2.5% 2.7% 2.73%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.83 0.81 0.82 0.86 0.88 0.90 0.90 0.92 0.90 0.92 0.90 0.89 0.81 0.77 0.71 0.68 0.68 0.73 0.78 0.87 0.869
Earnings Stability 0.80 0.72 0.77 0.79 0.86 0.84 0.85 0.85 0.79 0.81 0.78 0.70 0.54 0.46 0.40 0.24 0.13 0.05 0.01 0.00 0.000
Margin Stability 0.91 0.90 0.89 0.89 0.89 0.89 0.89 0.89 0.90 0.90 0.90 0.91 0.91 0.91 0.91 0.92 0.93 0.94 0.95 0.96 0.957
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.87 0.99 0.95 0.92 0.90 0.95 0.99 0.99 1.00 0.96 0.93 0.93 0.97 0.99 1.00 0.94 0.935
Earnings Smoothness 0.42 0.35 0.37 0.53 0.72 0.97 0.88 0.79 0.72 0.88 0.99 0.97 0.99 0.89 0.81 0.80 0.93 0.98 1.00 0.85 0.850
ROE Trend 0.11 0.15 0.11 0.10 0.06 0.01 -0.02 -0.05 -0.09 -0.09 -0.04 -0.05 -0.06 -0.07 -0.03 -0.03 -0.01 -0.01 -0.04 -0.01 -0.015
Gross Margin Trend 0.06 0.07 0.07 0.06 0.04 0.02 0.01 -0.00 -0.02 -0.02 -0.02 -0.03 -0.04 -0.04 -0.04 -0.03 -0.02 -0.01 -0.01 0.00 0.003
FCF Margin Trend -0.01 0.00 -0.02 0.00 0.01 0.00 0.02 0.01 0.01 0.01 0.01 -0.01 -0.01 -0.03 -0.05 -0.03 -0.02 -0.00 0.03 0.02 0.023
Sustainable Growth Rate 27.4% 32.8% 29.2% 30.2% 30.2% 27.6% 21.2% 19.8% 18.4% 20.0% 19.3% 18.4% 16.8% 15.8% 15.6% 14.7% 15.4% 15.5% 14.8% 16.4% 16.42%
Internal Growth Rate 22.4% 28.0% 25.0% 26.1% 26.2% 23.3% 18.1% 16.8% 15.4% 17.0% 16.8% 15.9% 14.3% 13.4% 13.1% 12.2% 12.9% 13.0% 12.3% 13.8% 13.84%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.96 0.93 0.88 0.94 0.98 1.04 1.24 1.29 1.36 1.37 1.31 1.33 1.43 1.41 1.33 1.42 1.39 1.41 1.53 1.32 1.318
FCF/OCF 0.57 0.60 0.57 0.59 0.59 0.59 0.61 0.58 0.56 0.55 0.53 0.51 0.47 0.46 0.42 0.46 0.51 0.55 0.62 0.64 0.640
FCF/Net Income snapshot only 0.844
OCF/EBITDA snapshot only 0.895
CapEx/Revenue 8.4% 8.6% 9.0% 9.2% 9.4% 9.2% 9.9% 10.4% 10.8% 11.9% 12.3% 12.6% 13.7% 13.2% 13.0% 12.4% 11.2% 10.4% 9.3% 8.0% 7.99%
CapEx/Depreciation snapshot only 1.958
Accruals Ratio 0.01 0.02 0.03 0.01 0.00 -0.01 -0.04 -0.05 -0.05 -0.06 -0.05 -0.05 -0.06 -0.05 -0.04 -0.05 -0.05 -0.05 -0.07 -0.04 -0.044
Sloan Accruals snapshot only 0.052
Cash Flow Adequacy snapshot only 2.242
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.2% 0.2% 0.1% 0.2% 0.2% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.2% 0.2% 0.3% 0.2% 0.4% 0.4% 0.3% 0.3% 0.3% 0.27%
Dividend/Share $0.66 $0.66 $0.67 $0.68 $0.69 $0.70 $0.72 $0.72 $0.74 $0.75 $0.76 $0.78 $0.79 $0.80 $0.80 $0.82 $0.83 $0.83 $0.84 $0.85 $0.87
Payout Ratio 9.6% 8.2% 7.7% 7.6% 7.6% 8.5% 9.2% 9.9% 10.8% 10.1% 9.6% 10.1% 11.1% 11.7% 12.0% 12.8% 12.3% 12.3% 12.4% 11.4% 11.39%
FCF Payout Ratio 17.3% 14.8% 15.5% 13.6% 13.1% 13.7% 12.3% 13.4% 14.1% 13.4% 13.8% 14.9% 16.3% 18.2% 21.4% 19.4% 17.5% 16.0% 13.1% 13.5% 13.49%
Total Payout Ratio 39.4% 33.6% 30.7% 32.0% 36.1% 43.7% 47.2% 33.1% 63.5% 59.0% 85.6% 1.2% 1.4% 1.5% 1.3% 1.0% 62.3% 51.2% 40.1% 66.4% 66.37%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.07 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.06 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.040
Buyback Yield 0.6% 0.5% 0.4% 0.5% 0.9% 1.2% 1.3% 0.5% 1.0% 1.0% 1.7% 2.2% 2.8% 3.1% 2.4% 2.6% 1.5% 1.0% 0.7% 1.6% 1.64%
Net Buyback Yield 0.6% 0.5% 0.4% 0.5% 0.9% 1.2% 1.3% 0.5% 1.0% 1.0% 1.7% 2.2% 2.8% 3.1% 2.4% 2.6% 1.5% 1.0% 0.7% 1.6% 1.58%
Total Shareholder Return 0.7% 0.6% 0.6% 0.7% 1.1% 1.5% 1.6% 0.7% 1.1% 1.2% 1.9% 2.4% 3.0% 3.4% 2.6% 3.0% 1.9% 1.3% 1.0% 1.9% 1.92%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.84 0.87 0.86 0.87 0.86 0.84 0.84 0.83 0.83 0.83 0.83 0.83 0.84 0.83 0.82 0.80 0.80 0.80 0.80 0.80 0.796
Interest Burden (EBT/EBIT) 1.03 1.02 1.02 1.02 1.01 1.01 1.02 1.02 1.02 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.02 1.02 1.02 1.021
EBIT Margin 0.24 0.26 0.27 0.27 0.27 0.26 0.24 0.23 0.22 0.23 0.24 0.23 0.21 0.21 0.20 0.20 0.20 0.20 0.20 0.21 0.207
Asset Turnover 0.98 1.04 0.93 0.94 0.96 0.95 0.83 0.83 0.83 0.84 0.79 0.79 0.77 0.77 0.77 0.77 0.79 0.81 0.78 0.81 0.814
Equity Multiplier 1.50 1.50 1.46 1.46 1.46 1.46 1.38 1.38 1.38 1.38 1.34 1.34 1.34 1.34 1.34 1.34 1.34 1.34 1.35 1.35 1.351
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $6.86 $8.06 $8.66 $9.01 $9.04 $8.33 $7.75 $7.29 $6.88 $7.43 $7.91 $7.65 $7.12 $6.81 $6.69 $6.40 $6.70 $6.76 $6.79 $7.50 $7.50
Book Value/Share $24.50 $24.40 $30.57 $30.73 $30.81 $30.85 $35.51 $35.47 $35.61 $35.66 $38.41 $38.78 $39.09 $39.25 $36.39 $36.74 $36.84 $36.90 $43.69 $43.87 $41.53
Tangible Book/Share $22.63 $22.54 $28.83 $28.98 $29.06 $29.10 $33.85 $33.81 $33.94 $33.99 $36.77 $37.11 $37.41 $37.57 $34.81 $35.14 $35.24 $35.29 $42.07 $42.24 $42.24
Revenue/Share $33.34 $35.29 $37.05 $37.89 $38.61 $38.40 $38.18 $38.08 $38.00 $38.86 $39.33 $39.42 $39.04 $39.19 $39.25 $39.67 $40.66 $41.50 $42.28 $44.48 $44.73
FCF/Share $3.80 $4.49 $4.33 $5.03 $5.30 $5.12 $5.81 $5.42 $5.26 $5.58 $5.53 $5.20 $4.85 $4.38 $3.75 $4.20 $4.73 $5.21 $6.45 $6.33 $6.36
OCF/Share $6.61 $7.53 $7.64 $8.51 $8.91 $8.64 $9.58 $9.39 $9.38 $10.20 $10.35 $10.18 $10.21 $9.57 $8.87 $9.10 $9.30 $9.54 $10.38 $9.88 $9.93
Cash/Share $8.13 $8.10 $9.98 $10.03 $10.06 $10.07 $11.83 $11.81 $11.86 $11.88 $11.39 $11.49 $11.59 $11.63 $6.58 $6.64 $6.66 $6.67 $10.88 $10.93 $7.24
EBITDA/Share $9.54 $10.61 $11.51 $11.75 $12.01 $11.44 $10.68 $10.31 $9.85 $10.63 $11.25 $10.99 $10.37 $10.14 $10.10 $10.01 $10.45 $10.62 $10.67 $11.04 $11.04
Debt/Share $4.30 $4.29 $4.26 $4.28 $4.29 $4.30 $4.21 $4.20 $4.22 $4.22 $4.12 $4.16 $4.19 $4.21 $4.14 $4.18 $4.19 $4.20 $5.73 $5.76 $5.76
Net Debt/Share $-3.83 $-3.81 $-5.72 $-5.75 $-5.77 $-5.78 $-7.62 $-7.61 $-7.64 $-7.65 $-7.27 $-7.33 $-7.39 $-7.42 $-2.43 $-2.46 $-2.46 $-2.47 $-5.15 $-5.17 $-5.17
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 13.029
Altman Z-Prime snapshot only 23.840
Piotroski F-Score 6 6 7 6 6 6 6 6 6 6 6 6 5 5 5 6 6 7 7 9 9
Beneish M-Score -2.27 -2.27 -2.17 -2.16 -2.15 -2.17 -2.58 -2.65 -2.68 -2.77 -2.76 -2.69 -2.70 -2.71 -2.53 -2.62 -2.65 -2.66 -1.24 -1.10 -1.098
Ohlson O-Score snapshot only -10.755
ROIC (Greenblatt) snapshot only 50.45%
Net-Net WC snapshot only $12.21
EVA snapshot only $246577653.21
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA+
Credit Score 93.77 93.57 93.28 93.81 94.63 94.28 95.71 95.06 95.44 95.34 95.45 95.13 95.50 95.31 95.23 94.81 95.13 94.64 95.31 94.66 94.657
Credit Grade snapshot only 2
Credit Trend snapshot only -0.154
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 85
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms